Mode
Text Size
Log in / Sign up
Phase 2 Completed N=11 Treatment

Remotely Supervised Transcranial Direct Current Stimulation (tDCS) for Primary Progressive Aphasia (PPA)

Primary Progressive Aphasia
Source: ClinicalTrials.gov NCT05615922 ↗
Enrolled (actual)
11
Serious AEs
0.0%
Results posted
Sep 2024
Primary outcomePrimary: Percentage of Participants Who Complete 16 Out of 20 Study Visits — 100 percentage of participants

Summary

The purpose of this study is to establish the feasibility of a program of remotely supervised transcranial direct current stimulation (RS-tDCS) paired with language skills practice for people living with the semantic or logopenic variants of primary progressive aphasia (PPA). There are currently no established standard-of-care treatments for PPA. This study will evaluate whether RS-tDCS combined with language skills practice is a feasible study design for individuals with PPA.

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of Participants Who Complete 16 Out of 20 Study Visits
100 —
SECONDARY
Number of Trained Language Probes at Treatment End
25.1 —
SECONDARY
Number of Untrained Language Probes at Treatment End
20.2 —
SECONDARY
Change in Aphasia Communication Outcome Measure (ACOM) Score
0.74 —
SECONDARY
Change in Stroke and Aphasia Quality of Life-39 Item (SAQOL-39) Score
-0.07 —
SECONDARY
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) - Social Roles and Activities Score
-1.2 —
SECONDARY
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) - Global Health Score
0.87 —
SECONDARY
Change in Quick Aphasia Battery (QAB) Score
0.14 —
SECONDARY
Change in Boston Naming Test (BNT)-Short Form Score
1.6 —
SECONDARY
Change in Controlled Oral Word Association Test (COWAT) Score
1.4 —

Eligibility Criteria

Inclusion Criteria

  • Primary progressive aphasia diagnosis (logopenic or semantic variant)
  • Peabody Picture Vocabulary Test (PPVT) score < -1.0 SD, serving as a literacy proxy for premorbid cognitive ability and ensuring English language fluency sufficient for participation in the study procedures.
  • WAIS-IV Matrix Reasoning T score < 20, serving as an index of current general cognitive functioning to exclude those with severe cognitive impairment
  • Stable and continuous access to internet service, email (WiFi "hotspot" to be provided if needed)
  • Fluent in English language (due to outcomes validated in English versions only)

Exclusion Criteria

  • Disorder other than PPA known to cause language dysfunction
  • Diagnosis of nonfluent/agrammatic subtype of primary progressive aphasia
  • History of traumatic brain injury
  • Uncontrolled seizure disorder and/or recent (<5 years) history of seizure
  • Metal implants in the head or neck
  • Any skin disorder or skin sensitive area near stimulation locations
  • Pregnant or breastfeeding
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05615922). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search